<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12">
 <label>12</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dehay</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Bourdenx</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Gorry</surname>
    <given-names>P.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Targeting 
   <italic>Î±</italic>-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
  </article-title>
  <source>
   <italic>The Lancet Neurology</italic>
  </source>
  <year>2015</year>
  <pub-id pub-id-type="doi">10.1016/s1474-4422(15)00006-x</pub-id>
 </element-citation>
</ref>
